Surrogate outcome measures

F. Ratjen (Toronto, Canada)

Source: Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis
Number: 5
Disease area: Paediatric lung diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Ratjen (Toronto, Canada). Surrogate outcome measures. Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical trials and outcome measures
Source: School Course 2013 - Primary ciliary dyskinesia: sharing knowledge and experience across Europe
Year: 2013


Assessment of patient-centred outcome
Source: Annual Congress 2007 - PG20 - Pulmonary rehabilitation: an update according to the new ATS/ERS guidelines
Year: 2007



Breath Holding Time in uncontrolled Asthma: associations with key physiological tests and patient-reported outcome measures
Source: International Congress 2019 – Exercise and physiotherapy in patients with asthma, cystic fibrosis, bronchiectasis and primary ciliary dyskinesia
Year: 2019


Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


Definition and outcome
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


PROMising developments in IPF patient-reported outcome measures
Source: Eur Respir J, 59 (1) 2102312; 10.1183/13993003.02312-2021
Year: 2022



Bedside weaning parameters as predictors of outcome
Source: Eur Respir J 2003; 22: Suppl. 45, 380s
Year: 2003

Patient-reported outcome measures after COVID-19: a prospective cohort study
Source: Eur Respir J, 56 (5) 2003276; 10.1183/13993003.03276-2020
Year: 2020



Is pathological response a valid surrogate for outcome?
Source: Virtual Congress 2021 – Hot topics in thoracic oncology
Year: 2021


Defining outcomes and markers
Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Year: 2007

Associations between PCD-specific health-related quality of life (QOL-PCD) outcomes and clinical measures
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018



Surrogate markers of right ventricular adaptation better predict long-term survival in patients with PAH than traditional prognostic variables
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013


Clinimetric properties of outcome measures in bronchiectasis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Beyond quality of life: important outcome variables that are influenced by long-term noninvasive ventilation
Source: International Congress 2017 – Home ventilation in COPD
Year: 2017


Assessment of patient reported outcomes
Source: ERS Course 2020 - Pulmonary rehabilitation
Year: 2020

Trends in primary outcome parameters for respiratory trials.
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


Markers of asthma outcome
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


Validation of the Bronchiectasis Impact Measure (BIM): a novel patient-reported outcome measure
Source: Eur Respir J, 57 (5) 2003156; 10.1183/13993003.03156-2020
Year: 2021